Literature DB >> 8544746

Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni.

L H Pereira1, P M Coelho, J O Costa, R T de Mello.   

Abstract

The compound Ro-15.5458/000, derivative in the class of 9-acridanone-hydrazones, was found to be effective against Schistosoma mansoni in mice, killing almost all the skin schistosomules (24 hr after infection), when administered at the dose of 100 mg/kg. In experiments carried out with Cebus monkeys, the drug was shown to be fully effective at 25 mg/kg, 7 days after infection. These data, associated with the good results obtained earlier at the post-postural phase of schistosomiasis, allow the inference that this promising compound may be important in the set of antischistosomal drugs, depending on further toxicological and clinical tests.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544746     DOI: 10.1590/s0074-02761995000300021

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

2.  Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone.

Authors:  Alexandra Probst; Cécile Häberli; Dionicio Siegel; Jianbo Huang; Seth Vigneron; Anh P Ta; Danielle E Skinner; Nelly El-Sakkary; Jeremiah D Momper; Jon Gangoiti; Yuxiang Dong; Jonathan L Vennerstrom; Susan A Charman; Conor R Caffrey; Jennifer Keiser
Journal:  J Antimicrob Chemother       Date:  2020-10-01       Impact factor: 5.790

Review 3.  Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?

Authors:  Godwin Akpeko Dziwornu; Henrietta Dede Attram; Samuel Gachuhi; Kelly Chibale
Journal:  RSC Med Chem       Date:  2020-04-06

Review 4.  Biological activities of hydrazone derivatives.

Authors:  Sevim Rollas; S Güniz Küçükgüzel
Journal:  Molecules       Date:  2007-08-17       Impact factor: 4.411

Review 5.  Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.

Authors:  Rashad A Abdul-Ghani; Naguiba Loutfy; Azza Hassan
Journal:  Parasitol Res       Date:  2009-07-09       Impact factor: 2.289

6.  Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.

Authors:  Edna de Farias Santiago; Sheilla Andrade de Oliveira; Gevânio Bezerra de Oliveira Filho; Diogo Rodrigo Magalhaes Moreira; Paulo André Teixeira Gomes; Anekécia Lauro da Silva; Andréia Ferreira de Barros; Aline Caroline da Silva; Thiago André Ramos Dos Santos; Valéria Rêgo Alves Pereira; Gabriel Gazzoni Araújo Gonçalves; Fábio André Brayner; Luiz Carlos Alves; Almir Gonçalves Wanderley; Ana Cristina Lima Leite
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.